Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
Teva Pharmaceuticals: We Make Quality Health Care Accessible
Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults ADDING MULTIMEDIA | BioSpace
Teva Announces New Brand Positioning and Visual Identity in North America
Teva secures US regulatory approval for generic version of Sabril
FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble
Teva, one of the biggest generic makers, joins the the brand-name club
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Teva Pharmaceuticals - Wikipedia
California bill would fight deals that delay generic drugs | Fierce Healthcare
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Image - Image of american, generics: 187803275
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva's $300 generic EpiPen now available in limited doses - Philadelphia Business Journal